Navigating BTK Inhibitors in Mantle Cell Lymphoma: Safety, Sequencing, and Evolving Pharmacist Roles
Expert insights on toxicity management, resistance mechanisms, and frontline integration of Bruton tyrosine kinase inhibitors in MCL.
Grace Baek, PharmD, BCOP
Advertisement
Articles by Grace Baek, PharmD, BCOP
Glofitamab-GemOx improves survival in transplant-ineligible patients with R/R DLBCL.
Peer Reviewed
This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Opportunities for further optimization of CML management remain.
New agents can offer a more tailored approach to therapy selection.
Melanoma is responsible for 80% of skin cancer deaths.
New therapeutics for prostate cancer must continue to be assessed for comparative safety and efficacy, as well as accessibility for patients.
Advertisement
Latest Updated Articles
Navigating Drug Resistance in Chronic Myelocytic LeukemiaOctober 13th 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Kidney Gap in Cardio-Kidney-Metabolic Care
2
FDA Approves At-Home Starting Dose of Lecanemab for Treatment of Alzheimer Disease
3
Pharmacists Can Catch Missed CKD With One Question
4
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes
5